Trial Profile
Symptomatic treatment using carbon dioxide in patients with perennial allergic rhinitis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 19 Jul 2017
Price :
$35
*
At a glance
- Drugs Carbon dioxide (Primary)
- Indications Allergic rhinitis
- Focus Therapeutic Use
- 29 Nov 2011 New trial record
- 01 Oct 2011 Results published in the Annals of Allergy, Asthma and Immunology.